| Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single … MB Moor, F Suter-Riniker, MP Horn, D Aeberli, J Amsler, B Möller, ... The Lancet Rheumatology 3 (11), e789-e797, 2021 | 219 | 2021 |
| Genetic predisposition in anti‐LGI1 and anti‐NMDA receptor encephalitis SH Mueller, A Färber, H Prüss, N Melzer, KS Golombeck, T Kümpfel, ... Annals of neurology 83 (4), 863-869, 2018 | 136 | 2018 |
| Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients S Dahlhaus, R Hoepner, A Chan, I Kleiter, O Adams, C Lukas, K Hellwig, ... Journal of Neurology, Neurosurgery & Psychiatry 84 (10), 1068-1074, 2013 | 119 | 2013 |
| Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab‐associated progressive multifocal leukoencephalopathy C Warnke, G von Geldern, P Markwerth, T Dehmel, R Hoepner, R Gold, ... Annals of neurology 76 (6), 792-801, 2014 | 102 | 2014 |
| Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations I Ayzenberg, R Hoepner, I Kleiter Therapeutics and clinical risk management, 261-272, 2016 | 95 | 2016 |
| A brief review of the effects of vitamin D on multiple sclerosis A Miclea, M Bagnoud, A Chan, R Hoepner Frontiers in immunology 11, 781, 2020 | 84 | 2020 |
| Efficacy and side effects of natalizumab therapy in patients with multiple sclerosis R Hoepner, S Faissner, A Salmen, R Gold, A Chan Journal of central nervous system disease 6, JCNSD. S14049, 2014 | 83 | 2014 |
| Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study I Ayzenberg, J Schöllhammer, R Hoepner, K Hellwig, M Ringelstein, ... Journal of neurology 263, 575-582, 2016 | 62 | 2016 |
| Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment S Faissner, R Hoepner, C Lukas, A Chan, R Gold, G Ellrichmann Therapeutic advances in neurological disorders 8 (5), 233-238, 2015 | 57 | 2015 |
| Successful treatment of anti-Caspr2 syndrome by interleukin 6 receptor blockade through tocilizumab C Krogias, R Hoepner, A Müller, C Schneider-Gold, A Schröder, R Gold JAMA neurology 70 (8), 1056-1059, 2013 | 54 | 2013 |
| Ictal autoscopic phenomena and near death experiences: a study of five patients with ictal autoscopies R Hoepner, K Labudda, TW May, M Schoendienst, FG Woermann, ... Journal of neurology 260, 742-749, 2013 | 47 | 2013 |
| Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis R Hoepner, M Bagnoud, M Pistor, A Salmen, M Briner, H Synn, L Schrewe, ... Acta neuropathologica 138, 443-456, 2019 | 46 | 2019 |
| Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational study A Miclea, VI Leussink, HP Hartung, R Gold, R Hoepner Journal of neurology 263, 1626-1632, 2016 | 46 | 2016 |
| Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course G Zoehner, A Miclea, A Salmen, N Kamber, L Diem, C Friedli, M Bagnoud, ... Therapeutic advances in neurological disorders 12, 1756286419878340, 2019 | 43 | 2019 |
| Teriflunomide and time to clinical multiple sclerosis in patients with radiologically isolated syndrome: the TERIS randomized clinical trial C Lebrun-Frénay, A Siva, MP Sormani, C Landes-Chateau, L Mondot, ... JAMA neurology 80 (10), 1080-1088, 2023 | 41 | 2023 |
| Neurofilament light chain elevation and disability progression in multiple sclerosis A Abdelhak, P Benkert, S Schaedelin, WJ Boscardin, C Cordano, ... JAMA neurology 80 (12), 1317-1325, 2023 | 36 | 2023 |
| Short‐and long‐term outcome and predictors in an international cohort of patients with neuro‐COVID‐19 E Beghi, R Helbok, S Ozturk, O Karadas, V Lisnic, O Grosu, T Kovács, ... European journal of neurology 29 (6), 1663-1684, 2022 | 35 | 2022 |
| Age‐dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross‐sectional study A Miclea, A Salmen, G Zoehner, L Diem, CP Kamm, ... CNS neuroscience & therapeutics 25 (4), 527-531, 2019 | 34 | 2019 |
| Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimod R Hoepner, J Havla, C Eienbröker, B Tackenberg, K Hellwig, I Meinl, ... Multiple Sclerosis Journal 20 (13), 1714-1720, 2014 | 33 | 2014 |
| Immunomodulatory treatment in postural tachycardia syndrome: a case series B Rodriguez, R Hoepner, A Salmen, N Kamber, WJ Z’Graggen European journal of neurology 28 (5), 1692-1697, 2021 | 32 | 2021 |
